Wheeler Bio is a disruptive new biopharmaceutical CDMO that brings biologics drug innovators, discovery CROs, and CDMOs together to solve an outdated industry bottleneck with a unique partnering model, built on shared success and lasting collaborations. The typical momentum drop between discovery and development poses significant challenges for emerging biopharma companies adding technical, financial, and regulatory risks. We believe these lifecycle challenges can be reduced with more democratization of manufacturing platforms. Wheeler's pioneering open-source development platform, Portable CMC™, delivers speed, efficiency, predictability, and freedom by integrating discovery CROs and CDMOs. Wheeler is proud to currently offer best-in class mammalian cell line development, GLP material supply, and an efficient path to GMP.
Wheeler Bio
Related Resources
Connectivity & Integration in Biomanufacturing
As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply risk-based thinking to manufacturing innovation.
Scalability, Quality, and Speed with Transposons
To solve for the significant bottlenecks often presented by conventional cell line development processes, this article discusses how Wheeler Bio is leveraging transposon-based gene delivery to compress timelines, increase clone stability, and offer...
Accelerating Time to IND with Pharma 4.0
The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation.